EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cardiovascular Protection with Sulfasalazine During Doxorubicin Challenge: Evidence from Oxidative and Histologic Endpoints

Onural Ozhan iD, Enes Kaya, Mehmet Hakan Tasolar, Mehmet Ertugrul Balkar iD, Azibe Yildiz iD, Feyzi Dogru iD, Zeynep Ulutas iD, Zeynep Kucukakcali iD, Hakan Parlakpinar iD

Biomolecules · 24.07.2026 · 16 (8) · 1085

DOI: 10.3390/biom16081085 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules, online erschienen am 24.07.2026. Verfasst von Onural Ozhan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Pharmacology, Faculty of Medicine, Inonu University, 44280 Malatya, Türkiye. Hauptthemen laut MEDLINE: Doxorubicin, Sulfasalazine, Cardiotoxicity, Cardiotonic Agents. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Türkiye Bilimsel ve Teknolojik Araştırma Kurumu, Inonu University, Scientific and Technological Research Council of Türkiye.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Anthracycline cardiotoxicity involves early oxidative–inflammatory injury to the myocardium and vasculature. Repurposing anti-inflammatory agents may offer pragmatic cardioprotection. The purpose of this study is to evaluate whether sulfasalazine (SSZ) mitigates doxorubicin (DOX)-induced myocardial and aortic injury in rats. Twenty-eight male Wistar albino rats were randomized to: Control (vehicle, n = 8), DOX (20 mg/kg i.p., single dose; n = 10), and SSZ + DOX (SSZ 300 mg/kg i.p. once daily for 3 days, then DOX 20 mg/kg i.p.; n = 10). At 24 h post-DOX, ECG and invasive blood pressure (BP) were recorded. The heart and thoracic aorta were harvested for histopathology and oxidative stress assays (MDA, SOD, GSH, CAT; composite indices where applicable). Compared with SSZ + DOX, the DOX group exhibited higher BP and greater arrhythmic burden. In the aorta, DOX elevated MDA and reduced SOD, GSH, and CAT versus the control, whereas SSZ + DOX shifted these toward control values. In the myocardium, DOX decreased SOD and increased oxidative index; SSZ + DOX attenuated histological injury (edema, hemorrhage, cardiomyocyte degeneration) and restored aortic intima–media thickness toward control. Heart rate was lower in SSZ + DOX than other groups. Short-course SSZ pretreatment alleviated early DOX-induced oxidative stress and structural damage in myocardial and aortic tissues, with concurrent improvement in hemodynamic and ECG profiles. These data support further dose–timing optimization and longer-term functional studies to define SSZ’s translational potential as an adjunct cardioprotective strategy during anthracycline exposure.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DoxorubicinSulfasalazineCardiotoxicityCardiotonic AgentsAnimalsOxidative StressMaleRatsRats, WistarMyocardium

Stichwörter der Autor:innen

aortadoxorubicinmyocardial injuryoxidative stressratsulfasalazine

Substanzen

DoxorubicinSulfasalazineCardiotonic Agents

Autor:innen und Institutionen

  • Department of Medical Pharmacology, Faculty of Medicine, Inonu University, 44280 Malatya, Türkiye.
  • Faculty of Medicine, Inonu University, 44280 Malatya, Türkiye.
  • Department of Cardiology, Faculty of Medicine, Inonu University, 44280 Malatya, Türkiye.
  • Department of Histology and Embryology, Faculty of Medicine, Inonu University, 44280 Malatya, Türkiye.
  • Department of Physiology, Faculty of Medicine, Malatya Turgut Ozal University, 44210 Malatya, Türkiye.
  • Department of Biostatistics and Medical Informatics, Faculty of Medicine, Inonu University, 44280 Malatya, Türkiye.

ORCID-Profile: Onural Ozhan, Mehmet Ertugrul Balkar, Azibe Yildiz, Feyzi Dogru, Zeynep Ulutas, Zeynep Kucukakcali, Hakan Parlakpinar

Förderung

  • Türkiye Bilimsel ve Teknolojik Araştırma Kurumu
  • Inonu University
  • Scientific and Technological Research Council of Türkiye

Zitieren

APA

Ozhan, O., Kaya, E., Tasolar, M. H., Balkar, M. E., Yildiz, A., Dogru, F., Ulutas, Z., Kucukakcali, Z., & Parlakpinar, H. (2026). Cardiovascular Protection with Sulfasalazine During Doxorubicin Challenge: Evidence from Oxidative and Histologic Endpoints. Biomolecules, 16(8), 1085. https://doi.org/10.3390/biom16081085

Vancouver

Ozhan O, Kaya E, Tasolar MH, Balkar ME, Yildiz A, Dogru F, et al. Cardiovascular Protection with Sulfasalazine During Doxorubicin Challenge: Evidence from Oxidative and Histologic Endpoints. Biomolecules. 2026;16(8):1085. doi:10.3390/biom16081085

BibTeX
@article{Ozhan2026,
  author = {Ozhan, Onural and Kaya, Enes and Tasolar, Mehmet Hakan and Balkar, Mehmet Ertugrul and Yildiz, Azibe and Dogru, Feyzi and Ulutas, Zeynep and Kucukakcali, Zeynep and Parlakpinar, Hakan},
  title = {Cardiovascular Protection with Sulfasalazine During Doxorubicin Challenge: Evidence from Oxidative and Histologic Endpoints},
  journal = {Biomolecules},
  year = {2026},
  volume = {16},
  number = {8},
  pages = {1085},
  doi = {10.3390/biom16081085}
}
Kostenlos starten →